View in EDS PDF Full Text

Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.

Saved in:
Bibliographic Details
Title: Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.
Authors: Nauck MA; Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-Universität Bochum), Bochum, Germany., Frossard JL; Division of Gastroenterology, University Hospital of Geneva, Geneva, Switzerland., Barkin JS; Division of Gastroenterology, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, FL., Anglin G; Eli Lilly Canada, Toronto, Ontario, Canada., Hensley IE; Eli Lilly and Company, Indianapolis, IN., Harper KD; Eli Lilly and Company, Indianapolis, IN., Milicevic Z; Eli Lilly and Company, Vienna, Austria milicevic_zvonko@lilly.com.
Source: Diabetes care [Diabetes Care] 2017 May; Vol. 40 (5), pp. 647-654. Date of Electronic Publication: 2017 Mar 10.
Publication Type: Journal Article
Journal Info: Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 28283565
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Nauck+MA%22">Nauck MA</searchLink>; Division of Diabetology, Medical Department I, St. Josef-Hospital (Ruhr-Universität Bochum), Bochum, Germany.<br /><searchLink fieldCode="AU" term="%22Frossard+JL%22">Frossard JL</searchLink>; Division of Gastroenterology, University Hospital of Geneva, Geneva, Switzerland.<br /><searchLink fieldCode="AU" term="%22Barkin+JS%22">Barkin JS</searchLink>; Division of Gastroenterology, Department of Medicine, University of Miami Leonard M. Miller School of Medicine, Miami, FL.<br /><searchLink fieldCode="AU" term="%22Anglin+G%22">Anglin G</searchLink>; Eli Lilly Canada, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hensley+IE%22">Hensley IE</searchLink>; Eli Lilly and Company, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Harper+KD%22">Harper KD</searchLink>; Eli Lilly and Company, Indianapolis, IN.<br /><searchLink fieldCode="AU" term="%22Milicevic+Z%22">Milicevic Z</searchLink>; Eli Lilly and Company, Vienna, Austria milicevic_zvonko@lilly.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227805975%22">Diabetes care</searchLink> [Diabetes Care] 2017 May; Vol. 40 (5), pp. 647-654. <i>Date of Electronic Publication: </i>2017 Mar 10.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Diabetes+Association%22">American Diabetes Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7805975 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1935-5548 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201495992%22">01495992 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Care <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28283565
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2337/dc16-0984
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 647
    Titles:
      – TitleFull: Assessment of Pancreas Safety in the Development Program of Once-Weekly GLP-1 Receptor Agonist Dulaglutide.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Nauck MA
      – PersonEntity:
          Name:
            NameFull: Frossard JL
      – PersonEntity:
          Name:
            NameFull: Barkin JS
      – PersonEntity:
          Name:
            NameFull: Anglin G
      – PersonEntity:
          Name:
            NameFull: Hensley IE
      – PersonEntity:
          Name:
            NameFull: Harper KD
      – PersonEntity:
          Name:
            NameFull: Milicevic Z
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2017 May
              Type: published
              Y: 2017
          Identifiers:
            – Type: issn-electronic
              Value: 1935-5548
          Numbering:
            – Type: volume
              Value: 40
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Diabetes care
              Type: main
ResultId 1